(Q30887333)

27 June 2017

28 June 2017

1 reference

title

Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients (English)

1 reference

10908468

27 June 2017

Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients (English)

1 reference

28 June 2017

1 reference

1 reference

2

P C Gotzsche

1 reference

27 June 2017

H K Johansen

1

2 references

27 June 2017

28 June 2017

1 January 2000

1 reference

10908468

27 June 2017

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

28 June 2017

2 references

27 June 2017

28 June 2017

CD000239

2 references

27 June 2017

28 June 2017

3

1 reference

10908468

27 June 2017

2

1 reference

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

28 June 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever--preliminary observations from a pilot, exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Nystatin prophylaxis and treatment in severely immunodepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Study of information submitted by drug companies to licensing authorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Must we really fear toxicity of conventional amphotericin B in oncological patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Effective and acceptable treatment for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Meta-analysis. Unresolved issues and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Publication bias: evidence of delayed publication in a cohort study of clinical research projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000239

10.1002/14651858.CD000239

21 January 2018

Identifiers

DOI

2 references

27 June 2017

28 June 2017

1 reference

27 June 2017

1 reference

12076388